Results 231 to 240 of about 353,556 (317)
The Induction and Abolition of Specific Immunosuppression of Heart Allografts in Rats by Use of Donor Blood and Cyclophosphamide [PDF]
Richard L. Marquet, GERARD A. HEYSTEK
openalex +1 more source
Cancer cell membrane‐based nanoparticles (CCM‐NPs) and cancer cell‐derived small extracellular vesicles (CsEVs) are emerging as promising drug delivery systems for targeted cancer treatment. Advances in nanotechnology have paved the way for innovative drug delivery systems that enhance the effectiveness of cancer treatment.
Wei Zhang+4 more
wiley +1 more source
Current and emerging approaches to cochlear immunosuppression with translation to human inner ear stem cell therapy: A systematic review. [PDF]
Creber NJ+5 more
europepmc +1 more source
Studies of Immunosuppression by Cobra Venom Factor [PDF]
Giorgio P. Martinelli+2 more
openalex +1 more source
Objective Our objective was to evaluate the efficacy and safety of subcutaneous (SC) abatacept and standard of care (SOC) for the treatment of idiopathic inflammatory myopathy (IIM) over 52 weeks. Methods In this randomized, double‐blind, placebo‐controlled phase III trial, patients with treatment‐refractory IIM received SC abatacept (at 125 mg weekly)
Rohit Aggarwal+5 more
wiley +1 more source
Association Between Early Immunosuppression Center Variability and One-Year Outcomes After Pediatric Liver Transplant. [PDF]
Raghu VK+15 more
europepmc +1 more source
IMMUNOSUPPRESSION BY THORACIC DUCT FILTRATION
Charles T. Fitts+5 more
openalex +1 more source
Objective The sparse effector “omnigenic” hypothesis postulates that the polygenic effects of common single nucleotide polymorphisms (SNPs) on a typical complex trait are mediated by trans effects that coalesce on expression of a relatively sparse set of core genes.
Athina Spiliopoulou+9 more
wiley +1 more source
Immunotherapy response in immunosuppressed patients with Merkel cell carcinoma: analysis of 183 patients. [PDF]
Gong E+10 more
europepmc +1 more source